GlaxoSmitline PLC (GSK)

Stay informed with GSK (GSK) share price, insights, and trends to support your trading strategy. Stay updated with FP Markets Chile.

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

GlaxoSmitline PLC (GSK) Profile

GlaxoSmithKline plc (GSK) was founded in London, England and established in 2000. GSK, according to Forbes, was the sixth largest pharmaceutical company in 2019. They provide a wide range of prescribed vaccines , consumer healthcare products and prescription medicines. GlaxoSmithKline (GSK) has a market capitalization of 71.57B USD. GSK has begun a few collaborations through the COVID-19 pandemic. Some of the them are Cananadian biopharmaceutical company, Medicago, CureVac. Also Gsk has announced an agreement in principle to support the manufacture of up to 60 million doses of Novavax’s COVID-19 vaccine candidate for use in the UK. Gsk is traded on the London Stock Exchange (LSE) and the Financial Times Stock Exchange index (FTSE 100) trading in regular trading session schedule (EST).

Start Trading GlaxoSmitline PLC (GSK) with a Market Leader Today

GlaxoSmitline PLC (GSK) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram